Bedford Consulting acquires Blooprint to significantly reinforce its position in France, with the support of Keensight Capital Press Release Bedford Consulting acquires Blooprint to significantly reinforce its position in France, with the support of Keensight Capital | Bedford…WeAreBlowJune 13, 2023
Keensight Capital expands its global presence with the opening of a North American office Press Release Keensight Capital expands its global presence with the opening of a North American office | Keensight…WeAreBlowJune 7, 2023
Keensight Capital appoints Rafe Hafeez as M&A Director Press Release Keensight Capital appoints Rafe Hafeez as M&A Director | Keensight…WeAreBlowMay 24, 2023
Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital Press Release Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital | Transaction…WeAreBlowApril 27, 2023
Keensight Capital appoints Cindy Giraud as Communications Director Press Release Keensight Capital appoints Cindy Giraud as Communications Director | Keensight…WeAreBlowMarch 20, 2023
Main Capital and Keensight Capital agree on the sale of Onventis, a leading cloud procurement provider for medium-sized businesses Press Release Main Capital and Keensight Capital agree on the sale of Onventis, a leading cloud procurement provider for medium-sized businesses | Keensight…WeAreBlowJanuary 26, 2023
inherent Group announces the acquisition of Equadex, an expert in IT solutions, and strengthens its local cloud offering Press Release inherent Group announces the acquisition of Equadex, an expert in IT solutions, and strengthens its local cloud offering | The…WeAreBlowJanuary 13, 2023
Valiantys sets strategy to strengthen its position in Europe by acquiring kreuzwerker’s Atlassian consulting business, with the support of Keensight Capital Press Release Valiantys sets strategy to strengthen its position in Europe by acquiring kreuzwerker’s Atlassian consulting business, with the support of Keensight Capital | Valiantys…WeAreBlowJanuary 11, 2023
Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Press Release Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities | Symeres,…WeAreBlowJanuary 10, 2023
Keensight Capital to acquire majority stake in Quanos Press Release Keensight Capital to acquire majority stake in Quanos WeAreBlowDecember 20, 2022